Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Qingdao Gaoce Technology
688556
5
Aerospace Nanhu Electronic Information Technology
688552
US OptionsDetailed Quotes
CTMX250516P1000
- 0.10
- 0.000.00%
15min DelayClose May 8 16:00 ET
0.00High0.00Low
0.10Open0.10Pre Close0 Volume59 Open Interest1.00Strike Price0.00Turnover230.58%IV17.43%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.3351Delta0.9842Gamma10.90Leverage Ratio-0.0087Theta-0.0001Rho-3.65Eff Leverage0.0006Vega
CytomX Newsroom
Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $2.5
Piper Sandler Initiates CytomX(CTMX.US) With Hold Rating, Announces Target Price $2.5
CytomX Therapeutics Analyst Ratings
Piper Sandler Maintains Overweight on CytomX Therapeutics, Lowers Price Target to $2.5
Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.5
Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.25
CytomX Therapeutics Analyst Ratings
H.C. Wainwright Maintains CytomX(CTMX.US) With Hold Rating
Barclays Remains a Buy on CytomX Therapeutics (CTMX)
Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.25
Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $5
CytomX Therapeutics (CTMX) Receives a Buy From Wedbush
Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.5
H.C. Wainwright Maintains CytomX(CTMX.US) With Hold Rating
CytomX Therapeutics Analyst Ratings
Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.5
H.C. Wainwright Maintains CytomX(CTMX.US) With Hold Rating
Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $3.25
Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.5
CytomX Therapeutics (CTMX) Receives a Buy From Barclays
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
